CA1252794A - Benzamide derivatives - Google Patents

Benzamide derivatives

Info

Publication number
CA1252794A
CA1252794A CA000445296A CA445296A CA1252794A CA 1252794 A CA1252794 A CA 1252794A CA 000445296 A CA000445296 A CA 000445296A CA 445296 A CA445296 A CA 445296A CA 1252794 A CA1252794 A CA 1252794A
Authority
CA
Canada
Prior art keywords
signifies
aminoethyl
compound
acid addition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000445296A
Other languages
English (en)
French (fr)
Inventor
Mose Da Prada
Renato Joos
Emilio Kyburz
Pierre C. Wyss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1252794A publication Critical patent/CA1252794A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000445296A 1983-03-03 1984-01-13 Benzamide derivatives Expired CA1252794A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.
CH1150/83 1983-03-03

Publications (1)

Publication Number Publication Date
CA1252794A true CA1252794A (en) 1989-04-18

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000445296A Expired CA1252794A (en) 1983-03-03 1984-01-13 Benzamide derivatives

Country Status (28)

Country Link
JP (1) JPS59167552A (de)
KR (1) KR910008202B1 (de)
AR (1) AR243155A1 (de)
AT (1) AT390948B (de)
AU (2) AU570431B2 (de)
BE (1) BE899059A (de)
CA (1) CA1252794A (de)
CH (1) CH653670A5 (de)
DE (1) DE3407654C2 (de)
DK (1) DK166382C (de)
ES (3) ES530230A0 (de)
FI (1) FI79297C (de)
FR (1) FR2541996B1 (de)
GB (1) GB2135998B (de)
GR (1) GR81866B (de)
HU (1) HU193556B (de)
IE (1) IE57004B1 (de)
IL (1) IL71078A (de)
IT (1) IT1173365B (de)
LU (1) LU85231A1 (de)
MC (1) MC1568A1 (de)
NL (1) NL8400459A (de)
NO (1) NO165999C (de)
NZ (1) NZ207272A (de)
PH (1) PH19623A (de)
PT (1) PT78187B (de)
SE (1) SE466447B (de)
ZA (1) ZA841394B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (de) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
PT78187A (en) 1984-04-01
IE57004B1 (en) 1992-03-11
DE3407654A1 (de) 1984-09-06
IE840512L (en) 1984-09-03
FR2541996B1 (fr) 1987-12-11
ES8504680A1 (es) 1985-05-01
SE466447B (sv) 1992-02-17
MC1568A1 (fr) 1985-02-04
SE8401190D0 (sv) 1984-03-02
NO165999C (no) 1991-05-15
GR81866B (de) 1984-12-12
KR910008202B1 (ko) 1991-10-11
ES530230A0 (es) 1985-05-01
ES537046A0 (es) 1985-08-16
NL8400459A (nl) 1984-10-01
GB2135998A (en) 1984-09-12
ES8506600A1 (es) 1985-08-16
FR2541996A1 (fr) 1984-09-07
ZA841394B (en) 1985-06-26
GB8405486D0 (en) 1984-04-04
ES8506601A1 (es) 1985-08-16
KR840009077A (ko) 1984-12-24
NO165999B (no) 1991-02-04
PT78187B (en) 1986-08-05
AU609758B2 (en) 1991-05-09
ES537045A0 (es) 1985-08-16
JPS59167552A (ja) 1984-09-21
AR243155A1 (es) 1993-07-30
GB2135998B (en) 1986-09-24
DK166382B (da) 1993-05-10
FI79297B (fi) 1989-08-31
BE899059A (fr) 1984-09-03
AU8307987A (en) 1988-06-16
LU85231A1 (de) 1985-09-12
HU193556B (en) 1987-10-28
AT390948B (de) 1990-07-25
JPH0430389B2 (de) 1992-05-21
SE8401190L (sv) 1984-09-04
DE3407654C2 (de) 1994-04-07
CH653670A5 (de) 1986-01-15
IL71078A0 (en) 1984-05-31
NZ207272A (en) 1987-07-31
DK147584D0 (da) 1984-02-29
FI79297C (fi) 1989-12-11
NO840797L (no) 1984-09-04
PH19623A (de) 1986-06-04
AU570431B2 (en) 1988-03-17
DK166382C (da) 1993-09-27
FI840734A0 (fi) 1984-02-22
DK147584A (da) 1984-09-04
IL71078A (en) 1987-12-31
ATA72484A (de) 1990-01-15
IT8419778A0 (it) 1984-02-23
FI840734A (fi) 1984-09-04
IT1173365B (it) 1987-06-24
AU2506684A (en) 1984-09-06

Similar Documents

Publication Publication Date Title
US5736559A (en) Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
HU184966B (en) Process for producing phenyl-piperazine derivatives of anti-agression activity
JPH06239822A (ja) 新規なｎ−ベンゾイルアミノ酸誘導体、これらの化合物を含有する医薬組成物およびこれらの化合物を製造する方法
KR960003810B1 (ko) 광학적 활성 벤젠 설폰아미드 유도체의 제조방법
JPS6197256A (ja) アルキルスルホンアミドフエニルアルキルアミン類
FR2785902A1 (fr) 4-aroylpiperidines antagonistes du recepteur du ccr-3, compositions pharmaceutiques les contenant, procede pour les utiliser et les preparer
CA2107223C (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
PL188012B1 (pl) Pochodne benzamidyny, sposób wytwarzania pochodnych benzamidyny i ich zastosowanie jako środki lecznicze
IE58788B1 (en) Ethylenediamine monoamide derivatives
CA1252794A (en) Benzamide derivatives
US5238962A (en) Benzamide derivatives
JP2003509505A (ja) 置換ピペラジン誘導体、それらの調製及び薬物としてのそれらの使用
KR910008183B1 (ko) 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법
KR900008133B1 (ko) 벤즈아미드의 제조방법
JPS61215361A (ja) 抗痙攣剤
JPS63222152A (ja) 抗痙攣剤
US4912135A (en) Amide compounds
CA1094070A (en) 1-phenyl-piperazine derivatives
JPS63216853A (ja) ２−アミノアセトアミド誘導体
KR900005018B1 (ko) 1-아로일-5-옥소-2-피롤리딘프로판산과 그의 에스테르 및 제조방법
US4851420A (en) 2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticals
CA1085855A (en) N-piperid-4-yl benzamide compounds
US4153702A (en) Basically alkylated dithiosalicyclic acid amides and their use as medicaments
CA1242200A (en) N-nitroso compounds, and their preparation and use
CS228531B2 (en) Method for the production of phenylpiperazine derivates

Legal Events

Date Code Title Description
MKEX Expiry